doi: 10.3390/cancers13153867 65 CemazarMMiklavcicDMirLMBelehradekJBonnayMFourcaultDet al
Swisher SG , Pataer A, Yu R, Nishizaki M, Fang B, Hunt KK, Roth JA
As Imperial College Londons Ivan Koychev noted: People exposed to GLP-1RAs over many years appear to have a lower risk of ever developing dementia, which suggests an influence on the earliest pathogenic processes rather than on established neurodegeneration. 2
To view or add a comment, sign in Genentech Reports the US FDA's Approval of Gazyva (Obinutuzumab) to Treat Lupus Nephritis #genentech #gazyva #obinutuzumab #lupusnephritis #usfda #regulatory #monoclonalantibody #nobility #regency #pii #piii #ro5072759 #rg7159 #r7159 #ga101 To view or add a comment, sign in Potential future royalty income from Metsera/Pfizer* obesity drug candidates As highlighted in our 2025 half-yearly results, IP Group has financial exposure to several of Metseras obesity drug programmes, following its acquisition of our former portfolio company Zihipp Limited in 2023
The identification of bee products that may enhance skin repair can contribute to a better understanding of the wound healing process and generate a new strategy to combat chronic wounds
